Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aknekit Step 1 is a topical cleansing formulation developed by TV TPI, specifically designed for the management of acne-prone skin. It serves as the initial phase of a multi-step dermatological regimen intended to treat acne vulgaris. The product is typically formulated as a cleansing gel and contains a combination of active ingredients, including salicylic acid, glycolic acid, and zinc gluconate. Salicylic acid, a beta-hydroxy acid (BHA), and glycolic acid, an alpha-hydroxy acid (AHA), function as keratolytics that exfoliate the skin surface and clear pores of sebum and cellular debris. Zinc gluconate provides complementary benefits by helping to regulate sebum production and exerting anti-inflammatory effects. Together, these components promote cellular turnover, reduce comedone formation, and prepare the skin for subsequent therapeutic applications.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Aknekit Step 1.